Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Neuroone Medical Technologies Corp and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$0.76-2.6%Nov 11 close
Reported results on October 5, 2026; they are not in these figures yet.
Next earnings: December 15, 2026
Figures through June 30, 2026, from the 10-Q filed August 13, 2026
Company outlook: revenue of about $10.5M for Fiscal year 2026 — up 15.4% on a year earlier